HCA Healthcare, Inc., through its subsidiaries, operates as a health care services company in the United States. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, and adolescent and adult alcohol and drug abuse treatment and counseling. In addition, the company operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. As of December 31, 2020, it operated 185 hospitals, which included 178 general, acute care hospitals, as well as five psychiatric hospitals and two rehabilitation hospitals; 121 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
IPO Year: 2011
Exchange: NYSE
Website: hcahealthcare.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/15/2025 | $425.00 | Equal-Weight → Underweight | Morgan Stanley |
| 10/14/2025 | $470.00 | Buy | Goldman |
| 7/28/2025 | Outperform → Peer Perform | Wolfe Research | |
| 7/16/2025 | $394.00 | Buy → Neutral | BofA Securities |
| 5/29/2025 | $385.00 | Underweight → Equal Weight | Wells Fargo |
| 4/15/2025 | $336.00 | Outperform → Neutral | Robert W. Baird |
| 12/17/2024 | $380.00 | Neutral | Analyst |
| 11/25/2024 | $400.00 → $320.00 | Equal Weight → Underweight | Wells Fargo |
| 11/22/2024 | Outperform → Mkt Perform | Raymond James | |
| 10/11/2024 | $475.00 | Overweight | KeyBanc Capital Markets |
8-K - HCA Healthcare, Inc. (0000860730) (Filer)
10-K - HCA Healthcare, Inc. (0000860730) (Filer)
8-K - HCA Healthcare, Inc. (0000860730) (Filer)
8-K - HCA Healthcare, Inc. (0000860730) (Filer)
10-Q - HCA Healthcare, Inc. (0000860730) (Filer)
FWP - HCA Healthcare, Inc. (0000860730) (Subject)
8-K - HCA Healthcare, Inc. (0000860730) (Filer)
8-K - HCA Healthcare, Inc. (0000860730) (Filer)
10-Q - HCA Healthcare, Inc. (0000860730) (Filer)
8-K - HCA Healthcare, Inc. (0000860730) (Filer)
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
Fastest customizable press release news feed in the world
HCA Healthcare, Inc. (NYSE:HCA) is scheduled to present at the following healthcare conferences: March 3, 2026 at 10:30am ET at the TD Cowen Health Care Conference March 4, 2026 at 9:50am ET at the Raymond James Institutional Investors Conference March 10, 2026 at 10:00am ET at the Leerink Partners Global Healthcare Conference March 10, 2026 at 2:00pm ET at the Barclays Global Healthcare Conference March 16, 2026 at 3:20pm ET at the Oppenheimer MedTech & Services Conference March 17, 2026 at 3:00pm ET at the KeyBanc Healthcare Forum A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relati
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that it has been named on Fortune's 2026 World's Most Admired Companies list. HCA Healthcare is ranked No. 1 in its industry again this year. "We are proud to again be recognized on Fortune's World's Most Admired Companies list," said Sam Hazen, CEO of HCA Healthcare. "I am grateful to our colleagues for the way they lead with compassion and the high standards they set across the organization as we work to improve outcomes and experiences for patients." Since 1997, Fortune has collaborated with Korn Ferry to determine the World's Most Admired Companies list. This year 685 companies across
44 hospitals ranked among America's 250 Best Hospitals HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that three of its hospitals were named among America's 50 Best Hospitals and 15 of its hospitals were named among America's 100 Best Hospitals by Healthgrades. These are part of the 44 HCA Healthcare hospitals recognized on the Healthgrades America's 250 Best Hospitals list for 2026. Inclusion on these lists recognizes superior performance in providing care for conditions and procedures across multiple specialty lines and areas. Mission Hospital in Asheville, North Carolina, HCA HealthONE Sky Ridge in Lone Tree, Colorado and HCA Florid
HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the fourth quarter ended December 31, 2025. Key fourth quarter metrics (all percentage changes compare 4Q 2025 to 4Q 2024 unless otherwise noted): Revenues increased 6.7 percent to $19.513 billion Net income attributable to HCA Healthcare, Inc. increased 30.6 percent to $1.878 billion Diluted earnings per share increased 44.6 percent to $8.14 per share, and diluted earnings per share, as adjusted, increased 28.8 percent to $8.01 per share Adjusted EBITDA increased 10.8 percent to $4.114 billion Cash flows from operating activities totaled $2.359 billion, compared to $2.559 billion in the fou
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that Erica Rossitto, MBA/HCM, BSN, RN, NEA-BC, has been promoted to senior vice president and chief nurse executive, effective February 1, 2026. In this role, Rossitto will lead the nursing agenda in advancing the practice of nursing among HCA Healthcare's more than 100,000 nurses. "Erica is an accomplished and respected leader who brings a deep understanding of nursing and clinical operations to this role," said Sam Hazen, CEO of HCA Healthcare. "I'm confident her demonstrated ability to unite teams, strengthen nursing leadership and drive innovation will continue to help support nurses and
HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 4Q 2025 Earnings Call When: Tuesday, January 27, 2026 at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced it will give $4.8 million to Pepperdine University to help launch the School of Nursing within the College of Health Science. This is part of HCA Healthcare's greater commitment to helping address the national nursing shortage. "We believe that investing in nursing education is vital to the future of healthcare," said Sammie Mosier, DHA, MA, BSN, NE-BC, senior vice president and chief nurse executive for HCA Healthcare. "It is a privilege to support Pepperdine University's new School of Nursing as they prepare the next generation of caregivers with the tools, confidence and compassion to care
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that it collected 19,846 pounds, approximately 13.6 million doses, of unused or expired medications during its seventh annual "Crush the Crisis" national prescription drug take back day. In total, the organization has now collected more than 108,500 pounds of medication since launching "Crush the Crisis" as an enterprise initiative in 2019. "I am incredibly proud of our organization in this milestone year," said Dr. Randy Fagin, senior vice president and chief quality officer at HCA Healthcare. "At our core, we are people taking care of people, and our annual Crush the Crisis take back day i
HCA Healthcare, Inc. (NYSE:HCA) is scheduled to present at the following healthcare conference: November 20, 2025 at 1:00pm CT at the 2025 Stephens Annual Investment Conference A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company's website, www.hcahealthcare.com. Dates and times may be subject to change, please check the conference schedule or the Investor Relations section of the Company's website for the latest information. About HCA Healthcare Nashville-based HCA Healthcare is one of the nation's leading providers of healthcare services comprising 191 hospital
Recognized as a Military Friendly employer by VIQTORY for 15 consecutive years HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced it will give $150,000 to multiple veteran support organizations in honor of Veterans Day. Since 2012, HCA Healthcare has hired more than 65,000 veterans, active-duty and reserve personnel and military spouses. This year, HCA Healthcare is giving: $50,000 to Operation Stand Down, an organization that engages veterans early in their transition from military service to find meaningful employment, to help expand their career services programs for transitioning service members, their families and veterans; $50,
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Morgan Stanley downgraded HCA from Equal-Weight to Underweight and set a new price target of $425.00
Goldman resumed coverage of HCA with a rating of Buy and set a new price target of $470.00
Wolfe Research downgraded HCA from Outperform to Peer Perform
BofA Securities downgraded HCA from Buy to Neutral and set a new price target of $394.00
Wells Fargo upgraded HCA from Underweight to Equal Weight and set a new price target of $385.00
Robert W. Baird downgraded HCA from Outperform to Neutral and set a new price target of $336.00
Analyst resumed coverage of HCA with a rating of Neutral and set a new price target of $380.00
Wells Fargo downgraded HCA from Equal Weight to Underweight and set a new price target of $320.00 from $400.00 previously
Raymond James downgraded HCA from Outperform to Mkt Perform
KeyBanc Capital Markets initiated coverage of HCA with a rating of Overweight and set a new price target of $475.00
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
Live Leadership Updates
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today presented its annual HCA Healthcare Awards of Distinction at a ceremony in Nashville, Tennessee. The HCA Healthcare Awards of Distinction—comprising the Frist Humanitarian Award and the Excellence in Nursing Award—are the highest honors HCA Healthcare bestows on employees, physicians and volunteers, recognizing the extraordinary individuals who exemplify the organization's culture and values. The Frist Humanitarian Award recognizes the highest achievements in serving others, and the HCA Healthcare Excellence in Nursing Award recognizes the highest levels of performance in the field of nursing. "The
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that its board of directors has appointed John W. Chidsey, III as an independent director, effective July 15, 2025. With his addition, HCA Healthcare's board of directors increases from nine to ten members. Mr. Chidsey will serve as a member of HCA Healthcare's audit and compliance committee, compensation committee and patient safety and quality of care committee. Mr. Chidsey most recently served as the global chief executive officer of Subway. He previously served as chief executive officer of Burger King Holdings, Inc. and held significant leadership roles at Cendant Corporation. Earlier
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that the HCA Healthcare Foundation has helped Girl Scouts of the USA (GSUSA) launch a new series of Mental Wellness Patch Programs to address mental wellness among girls in 4th through 12th grade. This is a result of the HCA Healthcare Foundation's $1.38 million grant to GSUSA, through its Healthier Tomorrow Fund, which was announced last year. "The HCA Healthcare Foundation has a long history of partnering with Girl Scouts nationally and locally. We are proud to deepen our partnership with Girl Scouts on this research-based mental wellness program," said Joanne Pulles, vice president of com
HCA Healthcare, Inc. (NYSE:HCA) today announced Jyric Sims, Ph.D., will become president of the company's West Florida Division, effective June 12. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230420005364/en/Jyric Sims, Ph.D. (Photo: Business Wire) Sims, who currently is CEO of HCA Healthcare's Medical City Plano and Medical City Frisco hospitals, will succeed Ravi Chari, M.D., who recently announced he will retire after 15 years with the company to pursue opportunities in early-stage healthcare companies. A more than 20-year healthcare veteran, Sims has been with HCA Healthcare since 2011. He has served as chief executive
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that Chuck Hall, HCA Healthcare's National Group president, will retire at the end of the year after nearly 36 years with the organization. Currently, Hall is responsible for HCA Healthcare's operations at 96 hospitals across 13 states. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220817005233/en/HCA Healthcare Announces Retirement of Longtime Senior Executive Chuck Hall (Photo: Business Wire) Over more than three decades, Hall has been influential in many successful initiatives that will benefit the company for years to come, inc
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that its board of directors has appointed Andrea B. Smith as an independent director. With her addition effective today, HCA Healthcare's board of directors increases from 10 to 11 members. Ms. Smith will serve as a member of HCA Healthcare's audit and compliance committee as well as the patient safety and quality of care committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220126005165/en/HCA Healthcare Appoints Andrea Smith as New Independent Director (Photo: Business Wire) Ms. Smith most recently served as Bank of America's
HCA Healthcare, Inc. (NYSE:HCA) today announced that its board of directors has appointed Hugh F. Johnston as an independent director, effective September 1, 2021. With his addition, HCA Healthcare's board of directors increases from 9 to 10 members. Mr. Johnston will also serve as a member of HCA Healthcare's audit and compliance committee and finance and investments committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210727005288/en/HCA Healthcare Appoints Hugh F. Johnston as New Independent Director (Photo: Business Wire) Mr. Johnston is vice chairman and chief financial officer of PepsiCo, Inc., a global food and bevera
This live feed shows all institutional transactions in real time.
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
SC 13G - HCA Healthcare, Inc. (0000860730) (Subject)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
Live finance-specific insights
HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the fourth quarter ended December 31, 2025. Key fourth quarter metrics (all percentage changes compare 4Q 2025 to 4Q 2024 unless otherwise noted): Revenues increased 6.7 percent to $19.513 billion Net income attributable to HCA Healthcare, Inc. increased 30.6 percent to $1.878 billion Diluted earnings per share increased 44.6 percent to $8.14 per share, and diluted earnings per share, as adjusted, increased 28.8 percent to $8.01 per share Adjusted EBITDA increased 10.8 percent to $4.114 billion Cash flows from operating activities totaled $2.359 billion, compared to $2.559 billion in the fou
HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 4Q 2025 Earnings Call When: Tuesday, January 27, 2026 at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://
Raises 2025 Guidance HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the third quarter ended September 30, 2025. Key third quarter metrics (all percentage changes compare 3Q 2025 to 3Q 2024 unless otherwise noted): Revenues increased 9.6 percent to $19.161 billion Net income attributable to HCA Healthcare, Inc. increased 29.4 percent to $1.643 billion Diluted earnings per share increased 42.6 percent to $6.96 per diluted share, and diluted earnings per share, as adjusted, increased 42.0 percent to $6.96 per diluted share Adjusted EBITDA increased 18.5 percent to $3.870 billion Cash flows from operating activities totaled $4.416 billion,
HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 3Q 2025 Earnings Call When: Friday, October 24, 2025 at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news
Raises 2025 Guidance HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the second quarter ended June 30, 2025. Key second quarter metrics (all percentage changes compare 2Q 2025 to 2Q 2024 unless otherwise noted): Revenues increased 6.4 percent to $18.605 billion Net income attributable to HCA Healthcare, Inc. increased 13.1 percent to $1.653 billion Diluted earnings per share increased 23.5 percent to $6.83 per diluted share, and diluted earnings per share, as adjusted, increased 24.4 percent to $6.84 per diluted share Adjusted EBITDA increased 8.4 percent to $3.849 billion Cash flows from operating activities totaled $4.210 billion, com
HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 2Q 2025 Earnings Call When: Friday, July 25, 2025 at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/
HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the first quarter ended March 31, 2025. Key first quarter metrics (all percentage changes compare 1Q 2025 to 1Q 2024 unless otherwise noted): Revenues totaled $18.321 billion Net income attributable to HCA Healthcare, Inc. totaled $1.610 billion, or $6.45 per diluted share Adjusted EBITDA totaled $3.733 billion Cash flows from operating activities totaled $1.651 billion Same facility admissions increased 2.6 percent and same facility equivalent admissions increased 2.8 percent "The solid fundamentals we saw in our business the past several quarters continued into the first quarter of 2025," said
HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 1Q 2025 Earnings Call When: Friday, April 25, 2025 at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/home/20250404757460/en/ INVESTOR CONTACT: Frank Morgan
HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the fourth quarter ended December 31, 2024. Key fourth quarter metrics (all percentage changes compare 4Q 2024 to 4Q 2023 unless otherwise noted): Revenues totaled $18.285 billion Net income attributable to HCA Healthcare, Inc. totaled $1.438 billion, or $5.63 per diluted share (which includes an estimated $0.60 per diluted share unfavorable impact from Hurricanes Helene and Milton) Adjusted EBITDA totaled $3.712 billion Cash flows from operating activities totaled $2.559 billion Same facility admissions increased 3.0 percent and same facility equivalent admissions increased 3.1 percent "
HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 4Q 2024 Earnings Call When: Friday, January 24, 2025 at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire